RT Journal Article
SR Electronic
T1 Bevacizumab (Avastin)
JF American Journal of Neuroradiology
JO Am. J. Neuroradiol.
FD American Society of Neuroradiology
SP 235
OP 236
DO 10.3174/ajnr.A1987
VO 31
IS 2
A1 Mukherji, S.K.
YR 2010
UL http://www.ajnr.org/content/31/2/235.abstract
AB SUMMARY: Bevacizumab is a humanized monoclonal antibody that was the first FDA approved therapy designed to inhibit angiogenesis. This paper will review the mechanism of action and clinical role of this antiangiogenic agent. FDAU.S. Food and Drug AdministrationVEGFvascular endothelial growth factor